clorazepate dipotassium has been researched along with flumazenil in 8 studies
| Studies (clorazepate dipotassium) | Trials (clorazepate dipotassium) | Recent Studies (post-2010) (clorazepate dipotassium) | Studies (flumazenil) | Trials (flumazenil) | Recent Studies (post-2010) (flumazenil) |
|---|---|---|---|---|---|
| 325 | 90 | 11 | 4,673 | 426 | 981 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beauvoir, C; Biboulet, P; Passeron, D | 1 |
| Baur, R; Sigel, E | 1 |
| Belzung, C; Chapouthier, G; Dodd, RH; Misslin, R; Vogel, E | 1 |
| Mormède, P | 1 |
| Dantzer, R; Mormede, P; Perio, A | 1 |
| Dantzer, R; Pério, A | 1 |
| Alzieu, M; Becquemont, L; Delhotal Landes, B; Guglielminotti, J; Guidet, B; Maury, E; Offenstadt, G | 1 |
| Capasso, A; Cavallo, F; Raffa, RB | 1 |
1 review(s) available for clorazepate dipotassium and flumazenil
| Article | Year |
|---|---|
[Neuroendocrine effects of benzodiazepines].
Topics: Adrenal Cortex Hormones; Anti-Anxiety Agents; Benzodiazepinones; Chlordiazepoxide; Clorazepate Dipotassium; Flumazenil; Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Male; Pituitary-Adrenal System; Prolactin; Stress, Psychological; Sympathetic Nervous System | 1983 |
7 other study(ies) available for clorazepate dipotassium and flumazenil
| Article | Year |
|---|---|
[Difficulties in antagonizing dipotassium chlorazepate using flumazenil in cases of acute poisoning].
Topics: Adult; Clorazepate Dipotassium; Drug Overdose; Female; Flumazenil; Humans; Male; Middle Aged | 1991 |
Allosteric modulation by benzodiazepine receptor ligands of the GABAA receptor channel expressed in Xenopus oocytes.
Topics: Animals; Benzodiazepines; Clorazepate Dipotassium; Electrophysiology; Flumazenil; gamma-Aminobutyric Acid; Ion Channels; Ligands; Oocytes; Osmolar Concentration; Receptors, GABA-A; Xenopus | 1988 |
Anxiogenic effects of methyl-beta-carboline-3-carboxylate in a light/dark choice situation.
Topics: Animals; Anxiety; Benzodiazepines; Carbolines; Choice Behavior; Clorazepate Dipotassium; Darkness; Dose-Response Relationship, Drug; Flumazenil; Light; Male; Mice | 1987 |
Relationship of the effects of the benzodiazepine derivative clorazepate on corticosterone secretion with its behavioural actions. Antagonism by Ro 15-1788.
Topics: Adrenal Cortex; Animals; Anti-Anxiety Agents; Benzodiazepinones; Brain; Clorazepate Dipotassium; Corticosterone; Flumazenil; Humans; Male; Pituitary-Adrenal System; Rats; Rats, Inbred Strains; Receptors, GABA-A; Stress, Psychological | 1984 |
Behavioural evidence for partial agonist properties of RO 15-1788, a benzodiazepine receptor antagonist.
Topics: Animals; Behavior, Animal; Benzodiazepinones; Clorazepate Dipotassium; Conflict, Psychological; Cues; Discrimination, Psychological; Flumazenil; Male; Pentylenetetrazole; Rats | 1982 |
Prolonged sedation requiring mechanical ventilation and continuous flumazenil infusion after routine doses of clorazepam for alcohol withdrawal syndrome.
Topics: Aged; Alcohol Withdrawal Seizures; Anticonvulsants; Antidotes; Bronchitis; Clorazepate Dipotassium; Coma; Fatal Outcome; Flumazenil; Humans; Infusions, Intravenous; Liver Diseases; Male; Middle Aged; Nordazepam; Pneumonia; Respiration, Artificial | 1999 |
Flumazenil-sensitive dose-related physical dependence in planarians produced by two benzodiazepine and one non-benzodiazepine benzodiazepine-receptor agonists.
Topics: Analysis of Variance; Animals; Benzodiazepines; Clorazepate Dipotassium; Dose-Response Relationship, Drug; Flumazenil; GABA Agonists; GABA Modulators; Locomotion; Midazolam; Planarians; Pyridines; Receptors, GABA-A; Reproducibility of Results; Substance Withdrawal Syndrome; Substance-Related Disorders; Zolpidem | 2007 |